NMDAR Hypofunction Animal Models of Schizophrenia

被引：91

作者：

Lee, Gloria ^{[1
]}

Zhou, Yi ^{[1
]}

机构：

[1] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA

来源：

FRONTIERS IN MOLECULAR NEUROSCIENCE | 2019年 / 12卷

关键词：

NMDAR; NMDAR hypofunction; NMDAR antagonists; knockout mice; schizophrenia; animal models; 14-3-3; proteins; MEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTORS; AUDITORY-EVOKED POTENTIALS; INDUCED COGNITIVE DEFICITS; TARGETED POINT MUTATIONS; SUBUNIT GENE GRIN2B; MICE LACKING; PREPULSE INHIBITION; 14-3-3; PROTEINS;

D O I：

10.3389/fnmol.2019.00185

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

The N-methyl-d-aspartate receptor (NMDAR) hypofunction hypothesis has been proposed to help understand the etiology and pathophysiology of schizophrenia. This hypothesis was based on early observations that NMDAR antagonists could induce a full range of symptoms of schizophrenia in normal human subjects. Accumulating evidence in humans and animal studies points to NMDAR hypofunctionality as a convergence point for various symptoms of schizophrenia. Here we review animal models of NMDAR hypofunction generated by pharmacological and genetic approaches, and how they relate to the pathophysiology of schizophrenia. In addition, we discuss the limitations of animal models of NMDAR hypofunction and their potential utility for therapeutic applications.

引用

页数：26

共 50 条

[1] Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia
Wu, Qiongqiong
Huang, Jing
Wu, Renrong
FRONTIERS IN NEUROSCIENCE, 2021, 15
[2] SHEDDING LIGHT ON THE MOLECULAR BASIS FOR NMDAR HYPOFUNCTION IN SCHIZOPHRENIA
Catts, Vibeke S.
Fung, Samantha
Newell, Kelly
Huang, Xu-Feng
Weickert, Cyndi Shannon
SCHIZOPHRENIA RESEARCH, 2012, 136 : S81 - S81
[3] Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia
Greene, R
HIPPOCAMPUS, 2001, 11 (05) : 569 - 577
[4] Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytes
Giuliana S. Zuccoli
Guilherme Reis-de-Oliveira
Bruna Garbes
Peter Falkai
Andrea Schmitt
Helder I. Nakaya
Daniel Martins-de-Souza
European Archives of Psychiatry and Clinical Neuroscience, 2021, 271 : 1579 - 1586
[5] Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
Giles E. Hardingham
Kim Q. Do
Nature Reviews Neuroscience, 2016, 17 : 125 - 134
[6] Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytes
Zuccoli, Giuliana S.
Reis-de-Oliveira, Guilherme
Garbes, Bruna
Falkai, Peter
Schmitt, Andrea
Nakaya, Helder, I
Martins-de-Souza, Daniel
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2021, 271 (08) : 1579 - 1586
[7] CORTICAL HYPODOPAMINERGIA VERSUS STRIATAL HYPERDOPAMINERGIA REVISITED IN AN NMDAR HYPOFUNCTION MODEL OF SCHIZOPHRENIA
Nakao, Kazuhito
Nakazawa, Kazutoshi
SCHIZOPHRENIA BULLETIN, 2017, 43 : S92 - S92
[8] NMDAR Hypofunction in Schizophrenia: D-serine Effects on Symptoms and Neural Biomarkers of Cortical Dysfunction in Schizophrenia
Javitt, Daniel C.
BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 10S - 11S
[9] TARGETING NMDAR HYPOFUNCTION DURING EARLY DEVELOPMENT FOR THE PREVENTION OF SCHIZOPHRENIA PHENOTYPES IN ADULTHOOD IN THE MAM MODEL
Gao, Wen-Jun
Xing, Bo
Li, Meng-lin
Gulchina, Yelena
SCHIZOPHRENIA BULLETIN, 2019, 45 : S154 - S154
[10] Neural substrates of cognitive impairment in a NMDAR hypofunction mouse model of schizophrenia and partial rescue by risperidone
Delgado-Sallent, Cristina
Gener, Thomas
Nebot, Pau
Lopez-Cabezon, Cristina
Puig, M. Victoria
FRONTIERS IN CELLULAR NEUROSCIENCE, 2023, 17

← 1 2 3 4 5 →